Acquired von willebrand disease: Correction of hemostatic defect by high‐dose intravenous immunoglobulins
- 1 June 1992
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 40 (2) , 151-152
- https://doi.org/10.1002/ajh.2830400214
Abstract
High‐dose intravenous immunoglobulins (ivIG) were used in a 57‐year‐old patient with acquired von Willebrand disease in order to correct a hemostatic defect before pneumonectomy for lung carcinoma. IvIG induced a rapid and complete correction of factor VIII (F VIII) and von Willebrand factor (vWF) and allowed surgery without additional factor coverage. F VIII and vWF returned to baseline values within 10 days after ivIG.Keywords
This publication has 4 references indexed in Scilit:
- Clinical Uses of Intravenous ImmunoglobulinsAnnals of Internal Medicine, 1990
- HIGH‐DOSE INTRAVENOUS GAMMAGLOBULIN FOR ACQUIRED VON WILLEBRAND'S DISEASEBritish Journal of Haematology, 1988
- ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULINThe Lancet, 1984
- Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathiesBlood, 1984